… treating a range of infectious diseases. Here, we review our current understanding of immune
checkpoint pathways in the pathogenesis of infectious diseases and discuss the potential …

… NK cells also express immune checkpoints and this may compromise their protective role
in early immune responses against cancer and infectious diseases. Expression of PD-1 is …

… immune checkpoints in cancer and infectious diseases. We also discuss the impact of the
bacterial microbiome on the relationship between cancer therapy and the immune system. …

… of several immune checkpoint molecules promotes antitumor immunity and increases … of
infection suggests that immune checkpoint molecules regulate the host immune responses to …

… This raises a conundrum, where inhibition of these checkpoints in patients could enhance …
to determine the impact of checkpoint blockade in the context of HIV infection. The majority of …

… In this study, the term “infectious disease” was defined as infection requiring the … Infectious
disease related to immune checkpoint inhibitor was defined as infection occurring at any time …

… Immune checkpoint inhibitor (ICI) antibodies constitute a new generation of cancer treatments,
associated with immune-related adverse events (irAEs). A previous retrospective study of …

… This section is focused on the risk of infection entailed by the use immune checkpoint
inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate (S1P) receptor modulators (fingolimod…

… All patients should probably be tested with an IGRA before the initiation of anti PD-1
treatment, and closer collaboration between infectious disease specialists and oncologists is …

… chronic infectious diseases. Immune checkpoint inhibition in infectious disease therapy
may be administered adjunctively to standard drug treatment − akin to cancer chemotherapy. …